Macrophages are key players in inflammation and atherosclerosis. They express surface receptors of different subtypes for the endogenous autocoid adenosine. Macrophages within atherosclerotic lesions attain two clear-cut functional phenotypes M1 (pro-inflammatory) and M2 (immunosuppressive). This study examines the relative expression of adenosine receptors and proteins involved in cholesterol transport in THP-1 human macrophages upon differentiation into M1 and M2 subtypes.
Introduction
Inflammation is the reaction of the immune system to infection or injury and has been implicated in the pathogeneses of multiple diseases such as arthritis, cancer, and stroke, as well as neurodegenerative and cardiovascular disorders [1] [2] [3] [4] . Intrinsically, inflammation is a beneficial event that leads to restoration of tissue structure and physiological functions. The macrophage is an integral part of innate and adaptive immunity and is composed of two subtypes that are either pro-inflammatory or anti-inflammatory [5] . The classically activated or M1 macrophage phenotype produces inflammatory cytokines, like tumor necrosis factor (TNF)-α, that trigger acute inflammation. The alternatively activated M2 phenotype is anti-inflammatory and has been found to play an important role in tissue and wound repair [6, 7] . Although the usual outcome of the acute inflammatory response is successful resolution and repair of tissue damage, dysfunction may predispose to autoimmunity, chronic inflammation, and accumulating tissue damage [8, 9] . Overproduction of M1 pro-inflammatory macrophages has also been linked to the development of atherosclerosis [10, 11] .
Stress and inflammation cause an interruption in oxygen supply (i.e., hypoxia) and accumulation of extracellular adenosine [12] [13] [14] . Adenosine signaling pathways are activated via one of its specific G-coupled protein receptors: A1R, A2AR, A2BR, and A3R. There is growing evidence that the function of the adenosine receptors is crucial in an anti-inflammatory response, reducing ischemiareperfusion injury in multiple organs [15] [16] [17] [18] . Previous studies demonstrate that A2AR and A3R activation inhibit the nuclear factor (NF)-κB signaling pathway. The NF-κB pathway triggers the transcription of the TNF-α gene [19, 20] . Hence, A2AR and A3R agonists are proposed as candidates for anti-rheumatic agents due to their ability to reduce expression of TNF-α [20, 21] . previous studies performed by our group [22, 23] and others [24] . The anti-atherogenic effect of activation of A2AR is attributed to its enhancement of reverse cholesterol transport by upregulating cholesterol 27-hydroxylase and the ATP binding cassette transporter A1 (ABCA1), a transporter that mediates cholesterol efflux to lipidpoor apolipoproteins [25] .
This study defines a link between changes in expression of adenosine receptors and cholesterol handling in polarized THP-1 human macrophages. Our results demonstrate that the M1 phenotype is associated with upregulation of the A2AR and A2BR while the M2 phenotype displays enhanced A1 and A3R expression. Accordingly, the M1 phenotype amasses less oxLDL than the M2 phenotype, which corresponds to reduced foam cell formation.
Materials and Methods

Cells and reagents
THP-1 monocytes were obtained from the American Type Culture Collection (Rockville, MD). Cell culture media and supplementary reagents were obtained from Invitrogen (Carlsbad, CA). Trizol reagent was purchased from Invitrogen (Carlsbad, CA). All reagents for reverse transcription-polymerase chain reaction (RT-PCR) were purchased from Applied Biosystems (Foster City, CA). SYBR Green Master mix for the quantitative real-time polymerase chain reaction (QRT-PCR) was obtained from Roche Applied Science (Penzberg, Germany). Primers used in amplification reactions were generated by Sigma-Genosys (St. Louis, MO).
Cell culture
Cell culture media and supplementary reagents were obtained from Invitrogen (Carlsbad, CA). The THP-1 human monocytic leukemia cell line was chosen for the study because it shares many properties with normal human monocytes, including expression of scavenger receptors and cholesterol transport proteins, and is a well-accepted model for atherosclerosis used in our laboratory [26, 27] and many others.
THP-1 monocytes (American Type Culture Collection, Manassas, VA) were grown at 37 o C in a 5% CO 2 atmosphere in RPMI 1640 supplemented with 10% fetal calf serum (FCS), 50 units/ml penicillin, and 50units/ml streptomycin. To facilitate differentiation into macrophages, THP-1 monocytes were treated with 100nM PMA for 24h at 37°C. When a differentiated non-polarized phenotype (M0) was achieved, the PMA-containing medium was removed, and replaced with complete RPMI 1640 supplemented with 10% FCS for another 24 hours.
In order to generate polarized phenotypes, cells were then cultured for 48 hours in the presence of 20ng/ml interferon-γ and 100ng/ml LPS to obtain M1 macrophages [28, 29] or 20ng/ml IL-4 to obtain M2 macrophages [30] . Phenotypes were confirmed via QRT-PCR analysis of gene expressions in commonly used cell surface markers IL-12, CCR7, and CXCL10 for M1 and CD163, mannose receptor, and CCL17 for M2 [31, 32] (Table 1) .
Phenotypical changes in macrophages were verified by flow cytometry using a BD Accuri C6 flow cytometer (BD Biosciences, Franklin Lakes, NJ). Both M1 and M2 phenotypes were stained with a PE conjugated mAb to CD163, a FITC conjugated mAb to CD68, an APC-conjugated mAb to CD11b, and a PE/Cy7 conjugated mAb to CD14, as well as isotype matched control mAbs, for 30 minutes at room temperature according to the manufacturer's instructions (Abcam, Cambridge, MA) [31] [32] [33] .
RNA extraction and real-time PCR
Immediately after the incubation period, total RNA was isolated with Trizol (Carlsbad, CA) reagent (1ml/10 6 cells). The quantity of total RNA from each condition was measured by absorption at 260 nm and 280nm wavelengths by ultraviolet spectrophotometry (Hitachi U2010 spectrophotometer). ABCA1, ABCG1, 27-hydroxylase, SR-B1, PPAR gamma, LXR alpha, LOX1, SR-A1, CXCL16, CD36, A1R, A2aR, and A3R mRNA were quantified by real-time PCR. The cDNA was copied from 1µg of total RNA using Moloney murine leukemia virus reverse transcriptase primed with oligo dT. Equal amounts of cDNA were taken from each RT reaction mixture for PCR amplification using specific primers ( Table 2) . QRT-PCR analysis was performed using the SYBR Green Reagent Kit according to the manufacturer's instructions on the Roche Light Cycler 480 (Roche Applied Science, Penzburg, Germany). Each reaction was done in triplicate. The amount of PCR products were estimated using Roche Applied Science software, provided by the manufacturer. Fluorescence emission spectra were monitored and analyzed. PCR products were measured by the threshold cycles (C T ), at which specific fluorescence becomes detectable. The C T value for each gene was normalized to that of glyceraldehydes-3-phosphate dehydrogenase (GAPDH), and the relative expression level was calculated as the mean value of the untreated THP-1 as 1. Nontemplate controls were included for each primer pair to check for significant levels of any contaminants. A melting-curve analysis was performed to assess the specificity of the amplified PCR products.
Protein extraction and western blot analysis
Cellular extracts were prepared with Lysis Kit -RIPA Buff er (ProteinSimple, Santa Clara, CA). The immunoreactive proteins were 
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Rabbit anti-human ABCA1 (sc-20794) (Santa Cruz, CA) and rabbit anti-human ABCG1 (ab-36969) (Abcam Inc., Cambrige, MA) were used as primary antibodies for detection of ABCA1 and ABCG1, respectively. Rabbit anti-human LOX1 (ab60178), CD36 (ab64014), SR-A1 (ab36625), CXCL16 (ab101404) were purchased from Abcam Inc. (Cambrige, MA). As a loading control, GAPDH was detected using rabbit anti-human GAPDH antibody (ab9485).
Quantization of detected proteins and image preparation were performed with Compass Software (ProteinSimple, Santa Clara, CA).
Evaluation of foam cell formation by DiI-oxLDL internalization assay
For the foam cell formation assay, cells were washed in distilled water and stained with 0.2% Oil Red O (Sigma, St. Louis, MO) for 30 min. After the PBS wash, cell nuclei were stained with hematoxylin (Sigma, St. Louis, MO) for 5 min. After a final wash with PBS, coverslips were mounted on slides using Permount solution (Sigma, St. Louis, MO). Foam cells, recognized as red-stained cells, were visualized via light microscopy (Axiovert 25; Carl Zeiss, Gottingen, Germany) with 40x magnification and photographed using a DC 290 Zoom digital camera (Eastman Kodak, Rochester, NY). The number of foam cells formed in each condition was calculated in triplicate manually and presented as percentage of total cells. Cells were incubated with 5 µg/ml 1,1'-dioctadecyl-3,3,3',3'tetramethylin docarbocyaninet (DiI)-oxLDL (Intracel, Frederick, MD) for 4h. Slides were prepared using Vectashield mounting medium containing DAPI stain (Vector Laboratories, Inc., Burlingame, CA). After incubation, accumulation of DiI-oxLDL in cells was determined by fluorescent intensity with a Nikon A1 microscopy unit with 40X magnification and photographed with a DS-Ri1 digital camera. Fluorescent intensity was quantified from at least 3 random fields (1024x1024 pixels) per slide, from 3 slides per experimental condition and graphed.
Data analysis
Statistical analysis was performed using Graphpad Prism, version 5.01 (GraphPad Software, San Diego, CA). All data were analyzed by one way ANOVA with a Bonferroni post hoc test to evaluate the statistical significance of intergroup differences in all the tested variables. P values <0.05 were considered statistically significant.
Results
Comparison of surface marker gene expression on THP-1 monocytes and M0, M1 and M2 macrophage subsets
M1 macrophages express IL-12, CCR7, and CXCL10 at significantly higher levels than M2 macrophages (P<0.001, n=3) ( Figure 1A -C). M2 macrophages express CD163, mannose receptor, and CCL17 at significantly higher levels than M1 macrophages (P<0.001, n=3) ( Figure 1D 
Expression of cholesterol efflux proteins: ABCA1, ABCG1, SR-B1 and 27 hydroxylase in different subsets of macrophages
M1 polarized macrophages display reduced expression of the major cholesterol efflux proteins at levels that significantly differ from the expression profile in M2 polarized macrophages ( Figure 2 ). Thus, level of ABCA1, SR-B1 and 27 hydroxylase (27OH) were 0.54 ± 0.052, 0.22 ± 0.04 and 0.15 ± 0.05 lower than non-polarized M0 macrophages (P<0.001, n=3). The level of ABCG1 was not significantly different (0.90 ± 0.06) upon activation of M1 phenotype compared to M0 and M2 (1.17 ± 0.016) ( Figure 2B ). In contrast, M2 macrophages exhibit upregulation in the expression of ABCA1 (1.49 ± 0.003) (P<0.001, n=3) ( Figure 2A ). Even though mRNA levels of SR-B1 and 27OH were significantly higher in M2 polarized macrophages versus M1, their levels were reduced as compared to M0 macrophages ( Figure  2C , D): 0.54 ± 0.013 and 0.38 ± 0.015, respectively (P<0.001, n=3) . Gene expression analysis was confirmed by Western blot (Figure  2E , F).
Expression of Scavenger Receptors: CD36, SR-A1, LOX1 and CXCL16 in Different Subsets of Macrophages
M1 differentiated macrophages express reduced levels of scavenger receptors: CD36, SR-A1 and LOX1 compared to M2 macrophages (Figure 3 ). Levels of CD36 and LOX1 were significantly lower: 0.84 ± 0.009 and 0.54 ± 0.004, respectively, compared to M0 non-polarized macrophages. In contrast, expression of CXCL16 was 10 fold higher compared to M0 and M2 macrophages (P<0.001, n=3) ( Figure 3D ). M2 polarized macrophages express 2 fold higher levels of CD36 and SR-A1 (P<0.011, n=3) and 4 fold higher LOX1 (P<0.011, n=3) ( Figure  3 A-C) . The level of CXCL16 was not affected by polarization to M2 phenotype ( Figure 3D ). Gene expression analysis was confirmed by Western blot (Figure 3E,F) .
DiI-oxLDL uptake and foam cell formation in different subsets of macrophages
In our study, M1 polarized macrophages uptake 1.5 times less DiI-oxLDL than M2 differentiated subset (P<0.001, n=3), as presented on microphotograph (x40x) ( Figure 4A ). Fluorescent intensity was quantified from at least 3 random fields (1024x1024 pixels) per slide, from 3 slides per experimental condition and graphed ( Figure 4B ). Lower lipid accumulation correlated with decrease in the foam cell formation in M1 versus M2 macrophages ( Figure 4A ). Consequently, M2 macrophages formed 25.5 ± 5.4% (P<0.001, n=5) more foam cells as compared to M1 subset ( Figure 4C ). Number of foam cells formed in each condition was calculated in triplicate manually and presented as percentage of total cells.
Expression of adenosine receptors on different subsets of human THP-1 macrophages
Upon polarization, M1 macrophages express 2.5 fold and 3 fold increased A2AR and A2BR, respectively (P<0.011, n=3) and a reduced amount of A3R (P<0.001, n=3) ( Figure 5B-D) compared to M0 and M2 subsets. In contrast, M2 macrophages display reduced level of A2AR (0.53 ± 0.022; P<0.001, n=3) and no significant difference in 
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level of A2BR versus M0 macrophages ( Figure 5B, Figure 5C ). M2 polarized macrophages express 1.5 fold increased A1R (P<0.001, n=3) and 2.2 fold higher A3R (P<0.001, n=3) ( Figure 5A ,D) compared to M0 and M1 macrophages.
Discussion
Macrophages promote atherogenesis by internalizing modified lipoproteins that have penetrated the vessel wall to form cholesterolloaded foam cells. The phenotypic switch in macrophages present in atherosclerotic lesions influences disease development and progression [34, 35] . Multiple studies have attempted to solve the M1/M2 macrophage polarization paradigm. It is generally accepted that the pro-inflammatory population is pro-atherogenic while the anti-inflammatory subset is atheroprotective [36, 37] . However, M1 and M2 macrophages both contribute during diverse stages of human plaque development and localize in distinct morphological points within atherosclerotic lesions. Further, the clearcut difference between M1 and M2 macrophages in vitro is probably not the natural circumstance. Degree of differentiation toward one state or the other In this study we demonstrate that the M1 phenotype expresses low levels of the proteins involved in cholesterol efflux -ABCA1 and SR-B1 as compared to M2 macrophages. These results are in accord with previous reports by Waldo et al, (2008) and Bouhlel et al, (2007) [34, 38] . We did not observed changes in the expression of ABCG1 in M1 and M2 subsets, compared to [34] , and down regulation of 27-hydroxylase, a protein that provides a pathway for elimination of intracellular cholesterol [39] , in both subsets compared to the M0 phenotype. These findings authenticate pro-atherogenic properties in the M1 subset of macrophages. However, expression of SR-B1 and 27-hydroxylase are lower in both M1 and M2 when compared to undifferentiated M0 macrophages ( Figure 2) . Moreover, M2 polarized macrophages display an increased expression of the major scavenger receptors responsible for modified lipid uptake: CD36, SR-A1 and LOX1. This supports the current model for increased lipid uptake in M2 macrophages as reported in Canton et al, (2013) [40] . In combination with the decreased level of cholesterol efflux proteins, this provides an explanation for observed difference in the internalization of oxLDL: significantly higher in M2 versus M1 (Figure 4 ). Lipid accumulation, in turn, leads to elevated foam cell production [40] , observed in the M2 population in our study. Interestingly, for the M1 set of macrophages, expression of only one scavenger receptor was increased -chemokine CXC ligand 16 (CXCL16) -a novel scavenger receptor, involved in oxLDL uptake [41] .
Despite documented differences in behavior of human and murine macrophages, a preponderance of our data regarding macrophage polarization originates in murine studies, while information on human macrophages remains sparse [42] . Further, the importance of adenosine receptors in atherosclerosis progression has been explored in murine models and not evaluated properly in humans. Thus, in the present study, conducted in a human cell line, we observed that M1 polarization is associated with upregulation of the A2AR and A2BR while M2 polarization enhances A1 and A3R expression.
While studies have shown possible beneficial effects of A2AR activation on the survival rate in septic murine models, recent evidence has shown that pharmacologic blockade of the A2AR using selective antagonists such as ZM-241385 decreases mouse mortality under septic conditions [17] . As these data occur in septic/inflammatory models where the distribution of polarized macrophages is shifted toward the M1 phenotype, future studies are indicated to further elucidate adenosine receptor activity in both M1 and M2 macrophages. Determining the effects of A2AR inhibition on macrophage polarization will also add to our understanding of the complicated physiology of adenosine action.
The clinical relevance of the present work is highlighted by the ongoing Cardiovascular Inflammation Reduction Trial (CIRT), an NIH-sponsored randomized, double blind, placebo-controlled clinical trial designed to determine whether low dose methotrexate will reduce recurrent cardiovascular events in 7,000 stable patients who are postmyocardial infarction or have documented coronary artery disease with type 2 diabetes or metabolic syndrome [43] . Atheroprotective effects of methotrexate are mediated, at least in part, through elevation of adenosine levels and thus the impact of methotrexate on the cardiovascular health of these patients may be dependent on macrophage phenotype in their arterial plaques [44] . Other potential approaches to controlling macrophage cholesterol accumulation may involve dietary supplements such as resveratrol which has low toxicity and may act on cholesterol transport proteins through adenosine or other signaling pathways [45, 46] Given the contrasting properties of pro-inflammatory M1 and antiinflammatory M2 macrophages in homeostasis and disease, considering the balance between these populations has been deemed crucial in 
